Eberl Margaret M, Watroba Nancy, Reinhardt Marc, Pomerantz Jay, Serghany Joseph, Broffman Gregory, Fox Chester H, Mahoney Martin C, Edge Stephen B
Department of Family Medicine, State University of New York at Buffalo, Buffalo, New York, USA.
Cancer. 2007 Aug 1;110(3):518-24. doi: 10.1002/cncr.22808.
Failure to obtain the requisite follow-up of patients with abnormal mammograms may delay cancer diagnosis and impact outcome. Up to 20% of women do not receive timely recommended follow-up. The current study tested the accuracy of the linkage of payer claims and clinical data to identify the appropriate treatment for patients with abnormal mammograms.
Electronic medical records in a staff model practice that was affiliated with a single health payer were scanned to identify the Breast Imaging Reporting and Data System (BI-RADS(R)) code for all mammograms. For each woman with a BI-RADS code 0, 3, 4, or 5 mammogram, the payer claims were searched for follow-up breast procedures (imaging, biopsy, and surgery) occurring within 2 months for BI-RADS code 0, 4, and 5 mammograms and within 8 months for BI-RADS code 3 mammograms. For women with >1 abnormal mammogram during the study period, only follow-up for the first abnormal mammogram was examined. The medical records of cases defined by claims as not having recommended follow-up care were reviewed to determine the accuracy of claims analyses.
A total of 17,329 women underwent 23,721 mammograms between January 1, 2001 and December 31, 2003. BI-RADS codes 0, 3, 4, or 5 occurred in 1,490 mammograms (6.3%). Among 1,206 women with a first abnormal mammogram who were eligible for claims follow-up, 16% did not receive recommended follow-up care. Medical record review demonstrated that the claims search accurately identified follow-up care in 97% of these cases.
Administrative claims supplemented with BI-RADS data were found to accurately identify the follow-up care of patients with abnormal mammograms. Case management using this method may assist physicians in ensuring that all patients receive appropriate care.
未能对乳房X光检查异常的患者进行必要的随访可能会延迟癌症诊断并影响治疗结果。高达20%的女性未得到及时的推荐随访。本研究测试了付款人索赔与临床数据关联的准确性,以确定乳房X光检查异常患者的适当治疗方法。
扫描与单一医疗付款人相关联的员工模式医疗机构的电子病历,以确定所有乳房X光检查的乳腺影像报告和数据系统(BI-RADS®)代码。对于每个BI-RADS代码为0、3、4或5的乳房X光检查女性,在付款人索赔中搜索在2个月内针对BI-RADS代码为0、4和5的乳房X光检查以及在8个月内针对BI-RADS代码为3的乳房X光检查进行的后续乳房检查程序(影像检查、活检和手术)。对于在研究期间有>1次异常乳房X光检查的女性,仅检查首次异常乳房X光检查的随访情况。对索赔定义为未接受推荐随访护理的病例的病历进行审查,以确定索赔分析的准确性。
在2001年1月1日至2003年12月31日期间,共有17329名女性接受了23721次乳房X光检查。1490次乳房X光检查(6.3%)出现了BI-RADS代码0、3、4或5。在1206名首次乳房X光检查异常且有资格进行索赔随访的女性中,16%未接受推荐的随访护理。病历审查表明,在这些病例中,97%的索赔搜索准确识别了随访护理。
发现补充了BI-RADS数据的行政索赔能够准确识别乳房X光检查异常患者的随访护理。使用这种方法进行病例管理可能有助于医生确保所有患者都能得到适当的护理。